Oridermyl ear gel
Oridermyl ear gel
Authorised
- Permethrin (25:75)
- Triamcinolone acetonide
- Nystatin
- NEOMYCIN SULFATE
Product identification
Medicine name:
Oridermyl ear gel
Active substance:
- Permethrin (25:75)
- Triamcinolone acetonide
- Nystatin
- NEOMYCIN SULFATE
Target species:
-
Dog
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
Permethrin (25:75)10.00/milligram(s)1.00gram(s)
-
Triamcinolone acetonide1.00/milligram(s)1.00gram(s)
-
Nystatin100000.00/international unit(s)1.00gram(s)
-
NEOMYCIN SULFATE4058.66/international unit(s)1.00gram(s)
Pharmaceutical form:
-
Gel
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Aluminium tube of 10g with high-density polyethylene cap
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol Ireland Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol S.A.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10983/040/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 1/12/2024